Stock Analiz

Lucid Diagnostics Inc. (LUCD) stock forecast and price target

Price $0.45 · data as of November 13, 2026

12-month price target

Average target$4.00
Upside / downside+790.7%
Analysts5
ConsensusStrong buy
Low $2.00Average $4.00High $9.50

Gold marker: average target · white marker: today’s price ($0.45)

Analyst ratings

Strong buy 1Buy 3Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.24+43.4%$6M
Next fiscal year
ends December 31, 2027
$-0.17+31.2%$18M
Next quarter
ends December 31, 2026
$-0.06+45.0%$2M
Quarter after
ends March 31, 2027
$-0.04+42.9%$3M

Consensus of the analysts covering Lucid Diagnostics, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.

Frequently asked questions

What is the Lucid Diagnostics stock price target?

The average 12-month target from 5 analysts is $4.00, 790.7% above the current price of $0.45 Targets range from $2.00 to $9.50.

Is Lucid Diagnostics a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 3 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Lucid Diagnostics expected to earn?

Analysts expect EPS of $-0.24 for the fiscal year ending December 31, 2026 and $-0.17 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.